Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.

MLA

Lacorte, Eleonora, et al. “Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.” Journal of Alzheimer’s Disease, vol. 87, no. 1, May 2022, pp. 101–29. EBSCOhost, https://doi.org/10.3233/JAD-220046.

APA

Lacorte, E., Ancidoni, A., Zaccaria, V., Remoli, G., Tariciotti, L., Bellomo, G., Sciancalepore, F., Corbo, M., Lombardo, F. L., Bacigalupo, I., Canevelli, M., Piscopo, P., & Vanacore, N. (2022). Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials. Journal of Alzheimer’s Disease, 87(1), 101–129. https://doi.org/10.3233/JAD-220046

Chicago

Lacorte, Eleonora, Antonio Ancidoni, Valerio Zaccaria, Giulia Remoli, Leonardo Tariciotti, Guido Bellomo, Francesco Sciancalepore, et al. 2022. “Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.” Journal of Alzheimer’s Disease 87 (1): 101–29. doi:10.3233/JAD-220046.